Department of Cardiovascular Medicine, Second Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China.
Department of Cardiovascular Medicine, Second Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China.
Diabetes Res Clin Pract. 2013 Jul;101(1):72-80. doi: 10.1016/j.diabres.2013.04.009. Epub 2013 May 18.
ATP binding cassette transporter G1 (ABCG1), a regulator of cholesterol efflux to HDL, has been shown to decrease in macrophages and smooth muscle cells under high glucose conditions. Endothelial cells have a high capacity to efflux sterols and express ABCG1. In the present study we explored the role of ABCG1 in high glucose-induced endothelial dysfunction.
Human aortic endothelial cells (HAECs) were cultured under high glucose conditions. ABCG1 mRNA and protein expression in HAECs were measured by real time PCR and Western blot. Cholesterol efflux and NO synthesis (NOS) activity were determined by means of scintillation counting. Total intracellular cholesterol was determined by gas-liquid chromatography. The secretion of IL-6 and ICAM-1 was measured using ELISA. The generation of intracellular reactive oxygen species (ROS) was measured using a fluorescence microscope.
We observed that high glucose suppressed ABCG1 expression and intracellular cholesterol efflux to HDL. Furthermore, high glucose increased the secretion of IL-6 and ICAM, as well as decreased phospho-eNOS protein expression and NOS activity. These processes were reversed by the up-regulation of ABCG1 using the liver X receptor (LXR) agonist T0901307 and an ABCG1 expression vector. In addition, high glucose-induced oxidative stress was reduced by the upregulation of ABCG1. In contrast, knock-down of ABCG1 in HAECs significantly increased the secretion of IL-6 and ICAM, as well as decreased phospho-eNOS protein expression and NOS activity.
The present results suggest that ABCG1 plays an important role in protecting against endothelial dysfunction induced by high glucose.
ATP 结合盒转运蛋白 G1(ABCG1)是胆固醇向 HDL 流出的调节剂,已显示在高葡萄糖条件下巨噬细胞和平滑肌细胞中的 ABCG1 减少。内皮细胞具有将固醇流出和表达 ABCG1 的高能力。在本研究中,我们探讨了 ABCG1 在高葡萄糖诱导的内皮功能障碍中的作用。
将人主动脉内皮细胞(HAEC)在高葡萄糖条件下培养。通过实时 PCR 和 Western blot 测量 HAEC 中的 ABCG1 mRNA 和蛋白表达。通过闪烁计数测定胆固醇流出和一氧化氮合酶(NOS)活性。通过气相色谱法测定总细胞内胆固醇。使用 ELISA 测量 IL-6 和 ICAM-1 的分泌。使用荧光显微镜测量细胞内活性氧(ROS)的产生。
我们观察到高葡萄糖抑制了 ABCG1 的表达和向 HDL 的细胞内胆固醇流出。此外,高葡萄糖增加了 IL-6 和 ICAM 的分泌,并降低了磷酸化 eNOS 蛋白表达和 NOS 活性。这些过程通过使用肝 X 受体(LXR)激动剂 T0901307 和 ABCG1 表达载体上调 ABCG1 而逆转。此外,高葡萄糖诱导的氧化应激通过上调 ABCG1 而减少。相比之下,HAEC 中的 ABCG1 敲低显着增加了 IL-6 和 ICAM 的分泌,并降低了磷酸化 eNOS 蛋白表达和 NOS 活性。
本研究结果表明,ABCG1 在保护高葡萄糖诱导的内皮功能障碍中发挥重要作用。